Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Impact BioMedical(IBO) the Revenue is 3 K (-57.14%);the EBIT is -702 K (+39.12%);the EPS is -0.01 (+99.15%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B57.14%
----
----
EBIT
-0.00B39.12%
----
----
EPS
-0.0199.15%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf